Janel CORP

Janel Corporation, through its subsidiary Antibodies Inc., has completed the acquisition of EnCor Biotechnology Inc. for $17 million, funded by operations, credit facilities, and a promissory note.

Janel Corporation stockholders elected all nominated directors and approved executive compensation at their annual meeting, opting for a three-year frequency for future advisory votes on executive pay.

Janel Corporation's Audit Committee has dismissed Prager Metis CPAs, LLC and engaged Baker Tilly US, LLP as its independent registered public accounting firm for the fiscal year 2026 audit, effective December 30, 2025.

Janel Corporation has entered into a new senior secured credit facility totaling up to $59.12 million to refinance existing debt and provide capital for future acquisitions.

Janel Corporation has finalized the transfer of its Janel Group LLC subsidiary to Rubicon Technology, Inc., significantly increasing its stake in Rubicon and initiating a tender offer.

Janel Corporation is transferring its wholly-owned subsidiary, Janel Group LLC, to Rubicon Technology, Inc. in exchange for a controlling stake and debt assumption.

Janel Corporation's Q2 2026 Form 10-Q filing reveals significant revenue increases, primarily from its Logistics segment, bolstered by strategic acquisitions and improved operational efficiencies.

Janel Corporation reports Q2 2026 revenue growth driven by acquisitions, despite lower net income and increased operating expenses.

Janel Corporation announced significantly improved financial results for the quarter and nine months ended June 30, 2025, primarily fueled by robust performance in its Logistics segment and contributions from recent acquisitions.

Janel Corporation's Q2 2025 results show significant revenue and profit growth, primarily driven by its Logistics segment.

Janel Corporation's Q1 2025 revenue increased by 25.1% year-over-year, primarily driven by its Logistics segment and the acquisition of Airschott.

Janel Corporation's Q3 2024 results show a mixed performance with revenue growth in some segments offset by declines in others, alongside strategic acquisitions impacting financials.

Janel Corporation announced a significant increase in net income and revenues for fiscal year 2025, driven by strong performance in its Logistics segment and strategic acquisitions across all business units.

Janel Corporation's fiscal year 2024 saw a slight revenue decrease but improved operating income, driven by strategic acquisitions and segment performance.

Ryan Karen Miller, a Director of Janel Corp, received 2,500 shares of common stock on October 1, 2026.

John Joseph Gonzalez Ii, a Director of Janel Corp, received 2,500 shares of common stock on October 1, 2026.

Kesteren Gerard Van, a Director of Janel Corp, received 2,500 shares of common stock on October 1, 2026.

Gregory J Melsen, a Director of Janel Corp, received 2,500 shares of common stock on October 1, 2026.

Gregory B Graves, a Director of Janel Corp, received 2,500 shares of common stock on October 1, 2026.

Gregory B Graves, a Director of Janel Corp, purchased 395 shares of common stock on September 11, 2026.

Janel Corporation announces its Annual Meeting of Stockholders on February 4, 2026, to vote on director elections, executive compensation, and say-on-pay frequency.

Janel Corporation's shareholders approved a Charter Amendment to restrict stock transfers, aiming to preserve over $190 million in Rubicon Technology's net operating losses.

Oaxaca Group, Dominique Schulte, and Darren Seirer have filed an Amendment No. 4 to Schedule 13D, disclosing an aggregate beneficial ownership of 40.9% of Janel Corp's common stock.